Preclinical efficacy and safety evaluation of BD211 autologous CD34+ hematopoietic stem cell injection for transfusion-dependent β-thalassemia in NCG-X mice
2025.02.10
Customizable virus-like particles deliver CRISPR-Cas9 ribonucleoprotein for effective ocular neovascular and Hungtington's disease gene therapy
2024.05.23
Identification of restrictive molecules involved in oncolytic virotherapy using genome-wide CRISPR screening
2023.11.01
In vivo CRISPR gene editing in patients with herpetic stromal keratitis.
2024.07.05
Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial
2024.05.07
Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers